Non-alcoholic fatty liver disease (NAFLD) and its more severe stage, non-alcoholic steatohepatitis (NASH), are becoming more common among children and adolescents in the United States and worldwide, coinciding with a rise in childhood obesity.

Experts recommend that children between the ages of 9 and 11 who are overweight, obese or have other risk factors should be screened for NAFLD.

Currently, there are no approved medications for the treatment of NAFLD and NASH, but these can be prevented or managed with lifestyle changes such as a healthy diet, weight loss and regular exercise.

Last Reviewed: January 27, 2023